Abbvie Inc
NYSE:ABBV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abbvie Inc
NYSE:ABBV
|
US |
|
V
|
Very Good Food Company Inc
XTSX:VERY
|
CA |
|
D
|
Discover Financial Services
XBER:DC7
|
US |
|
E
|
Equinor ASA
DUS:DNQ
|
NO |
|
Aeroports de Paris SA
OTC:AEOXF
|
FR |
|
TOMI Environmental Solutions Inc
NASDAQ:TOMZ
|
US |
|
Ningbo Zhoushan Port Co Ltd
SSE:601018
|
CN |
|
ASM International NV
AEX:ASM
|
NL |
|
Dios Fastigheter AB
STO:DIOS
|
SE |
|
Medtronic PLC
NYSE:MDT
|
IE |
Wall St Price Targets
ABBV Price Targets Summary
Abbvie Inc
According to Wall Street analysts, the average 1-year price target for ABBV is 257.6479 USD with a low forecast of 189.7588 USD and a high forecast of 344.4 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABBV's stock price target?
Price Target
257.6479
USD
According to Wall Street analysts, the average 1-year price target for ABBV is 257.6479 USD with a low forecast of 189.7588 USD and a high forecast of 344.4 USD.
What is the Revenue forecast for Abbvie Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Abbvie Inc?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 8 years is 11%.
What is the Net Income forecast for Abbvie Inc?
Projected CAGR
32%
Over the last 14 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 8 years is 32%.
